Cytosorbents Corp 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Beginning on December 23, 2014, our common stock began trading on Nasdaq under the symbol “CTSO.” Previously, the Company’s common stock traded in the over-the counter-market on the OTC Bulletin Board. Approximate Number of Equity Security Holders As of December 31, 2025, there were approximately 9,395 stockholders of record. Because shares of our common stock are held by depositaries, brokers and other nominees, the number of beneficial holders of our shares is larger than the number of stockholders of record. Issuer Purchases of Securities There were no repurchases of the Company’s securities during the year ended December 31, 2025. We have an effective shelf registration statement that was declared effective on September 30, 2024 with the SEC which enables us to raise up to $150 million in one or more offerings, through the issuance and sale of any combination of equity securities, debt securities, warrants and units. Approximately $149.7 million of this amount was available as of December 31, 2025. We have also allocated $20.0 million of our total shelf amount to our ATM facility. As of December 31, 2025, approximately $19.4 million was available for use under the ATM facility, subject to certain limitations. Recent Sales of Unregistered Securities We had no sales of unregistered securities in 2025 that have not been previously disclosed in a Current Report on Form 8-K or Quarterly Report on Form 10-Q. ​ Item 6. [Reserved] ​ ​